Granting Stock Acquisition Rights to Directors and Executive Officers
First written in FY2017-Q2. 2 of 4 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2020.
0 other companies' latest entry also says "Dropped".
- FY2020DroppedAnnual report
「From fiscal 2018, the company discontinued its stock-based compensation stock option plan and introduced a stock-based compensation plan for the company's directors, excluding outside directors and non-residents, and others (the "Plan").」
The company explicitly states that it discontinued its former stock-based compensation stock option plan and changed to a stock-based compensation plan using a BIP trust for executive compensation. - FY2018AdvancedAnnual report
「For the stock acquisition rights resolved on 20 July 2017, the unsettled balance at the end of the current consolidated fiscal year was 38,100 shares, while 15,900 shares vested and 15,900 shares were exercised.」
The company disclosed the vesting and exercise results for the stock acquisition rights granted in 2017. - FY2018-Q2AdvancedAnnual report
「The stock acquisition rights issued during the current second-quarter accounting period are as follows: Number of stock acquisition rights: 381; Number of shares underlying the stock acquisition rights: 38,100; Exercise period for the stock acquisition rights: from 8 August 2017 to 7 August 2047.」
The company disclosed an additional issue of 381 stock acquisition rights for directors, executive officers and others, representing 38,100 underlying shares. - FY2017-Q2First statedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
The company issued 682 stock acquisition rights for directors, executive officers and others, representing 68,200 underlying shares, with an exercise period from 6 August 2016 to 5 August 2046.